iNova Report issue

For profit Phase 1
Founded: Sydney Australia (2006)
Status: Acquired by Bausch Health Companies (2011)

Organization Overview

First Clinical Trial
2012
NCT01910090
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Dr. Rana T. Bustami

Active Ingredients

Drugs in Phase 1 Trials (2)

famotidine (pepcid) (1 trial)

flurbiprofen (ansaid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2